US 11820749
Centrally active and orally bioavailable uncharged bisoxime antidotes for organophosphate poisoning and methods for making and using them
granted A61PA61P39/02
Quick answer
US patent 11820749 (Centrally active and orally bioavailable uncharged bisoxime antidotes for organophosphate poisoning and methods for making and using them) held by The Regents of the University of California expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P39/02